Caio Max Sao Pedro Rocha Lima, MD, MS
- Professor, Hematology and Oncology
Caio Max Sao Pedro Rocha Lima, MD, MS
Research Interests
- Gastrointestinal Neoplasms
- Phase I Clinical Trials
- Education
- MD, Federal University of Bahia, 1990
- Internship
- Federal University of Bahia, 1990
- Residency
- Internal Medicine, Federal University of Bahia, 1992
- Hematology, Federal University of Bahia, 1994
- Fellowship
- Hematology / Oncology, Medical University of South Carolina College of Medicine, 1998
- Board Certifications
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Medical Oncology
- Positions
- Vardaman Buckalew Fund in Nephrology (Chair)
Professor, Hematology and Oncology - Departments and Affiliations
- Hematology and Oncology
- Comprehensive Cancer Center
Research
- A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere. Soares HP, Bayraktar S, Blaya M, Lopes G, Merchan J, Macintyre J, Mayo C, Green MR, Silva O, Levi J, Walker G, Rocha-Lima CM. Cancer Chemother. Pharmacol. 2014 Apr; 73(4):839-45.
- Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer. Palacio S, Loaiza-Bonilla A, Kittaneh M, Kyriakopoulos C, Ochoa RE, Escobar M, Arango B, Restrepo MH, Merchan JR, Rocha Lima CM, Hosein PJ. Anticancer Res. 2014 Jan; 34(1):301-6.
- Comparison of cancer care and outcomes between a public safety-net hospital and a private cancer center. Bayraktar UD, Warsch S, Chen E, Lima CM, Pereira D. J Health Care Poor Underserved. 2013 Aug; 24(3):1136-49.
- Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma. Bayraktar S, Rocha-Lima CM. . 2013 May; 4(2):29-42.
- A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer. Hosein PJ, de Lima Lopes G, Pastorini VH, Gomez C, Macintyre J, Zayas G, Reis I, Montero AJ, Merchan JR, Rocha Lima CM. Am. J. Clin. Oncol. 2013 Apr; 36(2):151-6.